A Look At Forward Guidance Issued by Pfizer Inc. (PFE) Within Their Quarterly Financial Filing
In the first quarter of 2025, the company faced revenue declines, largely due to Paxlovid, while operational expenses surged. Management is committed to enhancing R&D productivity and optimizing capital allocation,...









